Hormone fibroblast growth factor 21 holds promise for treating diabetes, obesity, and metabolic syndrome, but new drug treatments remain years away
- Despite some disappointing studies, researchers pursue IGF2 and other suspects for drug targets
- HYPERTENSION MYSTERY: A Case Study From ESAP™ A45-year-old woman presents with a nine-year history of hypertension. Her current antihypertensive medications include amlodipine, 10 mg dai...
- Glue secreted by these bivalves could prove effective in treatments for numerous cardiovascular diseases
- Deadly pancreatic cancer demands resourceful treatment approach